Rojas A, Delgado R, Glaría L, Palacios M
Pharmacology and Toxicology Department, Center of Pharmaceutical Chemistry, Havana, Cuba.
Biochem Biophys Res Commun. 1993 Oct 15;196(1):274-9. doi: 10.1006/bbrc.1993.2245.
We evaluated the effect of monocyte chemotactic protein-1 (MCP-1) on the induction of nitric oxide synthase activity in J774 cells. MCP-1 was able to inhibit the production of nitric oxide induced by LPS and IFN-gamma in a dose-dependent manner. Moreover, the inhibition was only achieved when the cells were pretreated with MCP-1. No inhibition was observed when MCP-1 was added after stimulation with LPS and IFN-gamma. These results demonstrate that MCP-1 is able to inhibit the induction of nitric oxide synthesis.